Clinical Trial: Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli

Brief Summary: In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.

Detailed Summary: In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.The primary outcome is clinical response and secondary outcomes are microbiological response and adverse events.
Sponsor: Mahidol University

Current Primary Outcome: Clinical response

Original Primary Outcome: Same as current

Current Secondary Outcome: Microbiological response

Original Secondary Outcome: Same as current

Information By: Mahidol University

Dates:
Date Received: March 7, 2006
Date Started: February 2006
Date Completion: December 2006
Last Updated: May 19, 2006
Last Verified: March 2006